Status:
UNKNOWN
Evaluation of CloudCare in the Treatment of Type 1 Diabetes
Lead Sponsor:
Diabeter Nederland BV
Conditions:
Type 1 Diabetes
Eligibility:
All Genders
16-75 years
Brief Summary
CloudCare is an eHealth application to help health care professionals (HCP) in the management/treatment of type 1 diabetes. The application will automatically check all uploaded glucose parameters fro...
Detailed Description
Diabeter offers a Conformité Européenne (CE) marked eHealth application called CloudCare. This is a customizable care management and decision support system that uses algorithms and automation to help...
Eligibility Criteria
Inclusion
- Willing to sign the study informed consent form prior to any data collection for this study
- Clinical diagnosis, based on investigator assessment, of type 1 diabetes and using insulin with or without metformin for at least 6 months.
- Age between 16 and 75 years old.
- Use of multiple daily injections of insulin (MDI, with a basal insulin injection and bolus injections) or continuous subcutaneous insulin infusion (CSII) with Flash or Continuous Glucose Monitoring (FGM/CGM), but without CloudCare for at least three months.
- Receiving CloudCare as part of their standard care for at least 6 months.
Exclusion
- Patients with type 1 diabetes on glucose lowering treatments other than insulin with or without metformin.
- Any known factor, condition, or disease that might interfere with study conduct or interpretation of the results, as deemed by the investigator.
Key Trial Info
Start Date :
June 20 2022
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
February 1 2025
Estimated Enrollment :
194 Patients enrolled
Trial Details
Trial ID
NCT05431140
Start Date
June 20 2022
End Date
February 1 2025
Last Update
September 1 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Diabeter
Rotterdam, South Holland, Netherlands, 3011 TA